1. Among GPP core functions, which one is the most difficult to implement in your country? And why? And what would be potential strategies to overcome? 2. What would be potential/feasible GPP model(s) which can be considered to implement in your country? 3. What are the facilitators for implementing GPP in your country?
[Lecture No. 2]: Ambulatory patient care 1. How to prevent medication error in your hospital or country ? ( for ambulatory care) Please state by four parts as bellow Prescription Dispensing Training program Other 2. Is there any procedure or device to make sure pharmacist acknowledge patient appropriately? Note : Please complete above question by word and power point file Power point : Please provide text and photo about your hospital condition in your slides to help us realize your condition and questions.
[Lecture No. 3]: Inpatient care 1. Please describe the inpatient pharmaceutical services, such as dispensing medications, screening medication orders for appropriateness, or identifying and reporting adverse drug reactions and medication errors, etc., in your hospital (country). 2. In order to comply with the WHO GPP guidelines, what will be the next pharmaceutical service (including quality improvement programs) that you want to implement in your institution? How are you going to evaluate the performance of this new service?
[Lecture No. 4]: Non-cytotoxic and cytotoxic sterile preparation <Not Yet Received from the Lecturer>
[Lecture No. 5]: Drug Procurement and inventory management 1. Are you satisfied the inventory control system in your hospital? After this lecture, what is your plan to improve it? 2. Do you think barcode implement is a good way for medication safety? Which step will you implement in the medication use process?
[Lecture No. 6]: Clinical pharmacy services and patient education 1. Please describe the manpower and highlight the current models of clinical pharmacy service in your hospital or in your country. 2. What are the current challenges for providing/developing clinical pharmacy services in your country/hospital settings? 3. Please prioritize the types of clinical pharmacy services which can be implemented in your country/hospital settings.
[Lecture No. 7]: Drug information and nationwide reporting systems 1. (1) What information service you have not provided to patients but you want to start now? Share and compare your current service with team members. (2) Please design a protocol of information service for your pharmacy. (20 mins discussion, 5 mins report) 2. Please compare the current reporting system in your practice with those in your team members about: How do you report the adverse drug reactions and/or medication errors? How do you feedback to patients and healthcare professionals about the findings from reporting systems? Is there any difference? What have you learned from your members or from this workshop and what will you like to apply to your practice? (20 mins discussion, 5 mins report)
[Lecture No. 8]: Continuing professional development Before coming to the meeting, the representative of each country should provide brief introduction focusing on following 3 aspects in fulfilling the CPD of WHO GPP guideline and share the experience in speaking while attending this lecture personally. @ CPD program on new pharmacy graduates ^ The duration of program ^ Definition of new graduate ^ Qualification of the trainer ^ The source of financial support ^ Other information @ Pharmacist advancement program ^ The number of advancement levels ^ The elements of requirement in the advancement program ^ The relationship of the advancement levels and salary @ Required continuing education credits for renewing pharmacist licensure ^ Number of credit hours in number of years ^ Any required credit hours on specific subjects among the total required credit hours ^ The requirement for a CE approval organization